Alpine Immune Sciences Inc (NASDAQ:ALPN)

9.33
Delayed Data
As of 3:59pm ET
 +0.28 / +3.09%
Today’s Change
6.66
Today|||52-Week Range
16.37
-25.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$220.0M

Company Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases; immuno-oncology; and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.

Contact Information

Alpine Immune Sciences, Inc.
188 East Blaine Street
Seattle Washington 98102
P:(206) 788-4545
Investor Relations:

Employees

Shareholders

Individual stakeholders52.00%
Other institutional35.86%
Mutual fund holders3.67%

Top Executives

Mitchell H. GoldExecutive Chairman & Chief Executive Officer
Stanford L. PengPresident & Head-Research & Development
Thaedra ThullberryFinance Director
James Paul RickeyChief Financial Officer, Secretary & Senior VP
Wayne R. GombotzChief Technology Officer